Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness. - Wang Y; Bukkems LH; Ter Heine R; van Hasselt JGC; Koolen SLW; Hendrikx JJMA; Van der Hulle T; Kapiteijn E; Zwaveling J; Becker A; van den Heuvel MM; Theelen WSME; et al. (Clinical pharmacokinetics, 2026)